Our five corporate units, Corporate Strategy, Corporate Planning & Management, Digital Transformation Management, Business Development, and Corporate Affairs support, our CEO in developing comprehensive and consistent corporate strategies and ensuring smooth management of the Daiichi Sankyo Group.
Our six functional units, Research & Development, Biologics, Pharmaceutical Technology, Supply Chain, Quality Assurance & Regulatory Affairs, and Clinical Safety & Pharmacovigilance, help formulate and execute global strategies in their specialties. Each unit determines areas to be expanded globally, guides strategic planning and execution, and improves the efficiency of business operations.
Our six business units are responsible for strategic planning and execution in the regions of our business operations.
Japan Business Unit
Oncology Business Unit
EU Specialty Business Unit
ASCA Business Unit
American Regent Business Unit
Daiichi Sankyo Healthcare Unit